Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

Wockhardt’s next act: From generics to global innovator

Posted on July 7, 2026
By Financial Express
0 Views
1 min read

Wockhardt’s next act: From generics to global innovator

Wockhardt transforms from generics maker to global innovator with FDA-approved antibiotic Zaynich, addressing antimicrobial resistance and bolstering India's original drug discovery legacy.